Orthopediatrics Corp (KIDS)

$31.86

-1

(-3.04%)▲

Live

Performance

  • $31.55
    $33.26
    $31.86
    downward going graph

    0.97%

    Downside

    Day's Volatility :5.14%

    Upside

    4.21%

    downward going graph
  • $23.10
    $43.17
    $31.86
    downward going graph

    27.5%

    Downside

    52 Weeks Volatility :46.49%

    Upside

    26.2%

    downward going graph

Returns

PeriodOrthopediatrics CorpSector (Health Care)Index (Russel 2000)
3 Months
8.59%
6.5%
0.0%
6 Months
24.61%
7.1%
0.0%
1 Year
-23.3%
9.8%
0.0%
3 Years
-45.21%
14.2%
-20.2%

Highlights

Market Capitalization
805.5M
Book Value
$15.74
Earnings Per Share (EPS)
-0.93
Wall Street Target Price
42.5
Profit Margin
-13.58%
Operating Margin TTM
-21.76%
Return On Assets TTM
-3.89%
Return On Equity TTM
-5.91%
Revenue TTM
161.8M
Revenue Per Share TTM
7.11
Quarterly Revenue Growth YOY
41.5%
Gross Profit TTM
90.7M
EBITDA
-8.3M
Diluted Eps TTM
-0.93
Quarterly Earnings Growth YOY
0.0
EPS Estimate Current Year
-1.18
EPS Estimate Next Year
-1.13
EPS Estimate Current Quarter
-0.4
EPS Estimate Next Quarter
-0.25

Analyst Recommendation

Buy
    76%Buy
    23%Hold
    0
    0%Sell
Based on 13 Wall street analysts offering stock ratings for Orthopediatrics Corp(by analysts ranked 0 to 5 stars)
Based on 13 analyst
  • Current
  • 1M Ago
  • 3M Ago
Buy
10
10
10
Hold
3
3
3
Sell
00
00
00

Analyst Forecast

What analysts predicted

Upside of 33.4%

Current $31.86
Target $42.50

Company Financials

FY18Y/Y Change
Revenue
57.6M
↑ 26.17%
Net Income
-12.0M
↑ 34.63%
Net Profit Margin
-20.89%
↓ 1.31%
FY19Y/Y Change
Revenue
72.6M
↑ 26.05%
Net Income
-17.2M
↑ 43.03%
Net Profit Margin
-23.71%
↓ 2.82%
FY20Y/Y Change
Revenue
71.1M
↓ 2.03%
Net Income
-32.9M
↑ 91.55%
Net Profit Margin
-46.35%
↓ 22.64%
FY21Y/Y Change
Revenue
98.0M
↑ 37.95%
Net Income
-16.3M
↓ 50.64%
Net Profit Margin
-16.58%
↑ 29.77%
FY22Y/Y Change
Revenue
122.3M
↑ 24.72%
Net Income
1.3M
↓ 107.74%
Net Profit Margin
1.03%
↑ 17.61%
FY23Y/Y Change
Revenue
148.7M
↑ 21.62%
Net Income
-21.0M
↓ 1767.25%
Net Profit Margin
-14.1%
↓ 15.13%
Q4 FY22Q/Q Change
Revenue
31.0M
↓ 11.32%
Net Income
-7.8M
↓ 142.34%
Net Profit Margin
-25.32%
↓ 78.36%
Q1 FY23Q/Q Change
Revenue
31.6M
↑ 1.92%
Net Income
-6.8M
↓ 13.29%
Net Profit Margin
-21.55%
↑ 3.77%
Q2 FY23Q/Q Change
Revenue
39.6M
↑ 25.23%
Net Income
-2.9M
↓ 57.6%
Net Profit Margin
-7.3%
↑ 14.25%
Q3 FY23Q/Q Change
Revenue
40.0M
↑ 1.04%
Net Income
-4.6M
↑ 59.08%
Net Profit Margin
-11.49%
↓ 4.19%
Q4 FY23Q/Q Change
Revenue
37.6M
↓ 5.9%
Net Income
-6.7M
↑ 45.74%
Net Profit Margin
-17.79%
↓ 6.3%
Q1 FY24Q/Q Change
Revenue
44.7M
↑ 18.8%
Net Income
-7.8M
↑ 16.65%
Net Profit Margin
-17.47%
↑ 0.32%
FY18Y/Y Change
Total Assets
112.1M
↑ 36.21%
Total Liabilities
30.4M
↓ 12.74%
FY19Y/Y Change
Total Assets
194.6M
↑ 73.56%
Total Liabilities
52.2M
↑ 71.87%
FY20Y/Y Change
Total Assets
320.4M
↑ 64.68%
Total Liabilities
85.6M
↑ 64.06%
FY21Y/Y Change
Total Assets
304.3M
↓ 5.04%
Total Liabilities
78.9M
↓ 7.87%
FY22Y/Y Change
Total Assets
427.7M
↑ 40.57%
Total Liabilities
49.1M
↓ 37.8%
FY23Y/Y Change
Total Assets
449.6M
↑ 5.11%
Total Liabilities
72.6M
↑ 47.85%
Q4 FY22Q/Q Change
Total Assets
427.7M
↓ 0.54%
Total Liabilities
49.1M
↑ 5.04%
Q1 FY23Q/Q Change
Total Assets
426.3M
↓ 0.34%
Total Liabilities
53.1M
↑ 8.26%
Q2 FY23Q/Q Change
Total Assets
434.9M
↑ 2.01%
Total Liabilities
54.6M
↑ 2.68%
Q3 FY23Q/Q Change
Total Assets
432.4M
↓ 0.56%
Total Liabilities
58.1M
↑ 6.52%
Q4 FY23Q/Q Change
Total Assets
449.6M
↑ 3.96%
Total Liabilities
72.6M
↑ 24.86%
Q1 FY24Q/Q Change
Total Assets
437.2M
↓ 2.76%
Total Liabilities
66.6M
↓ 8.21%
FY18Y/Y Change
Operating Cash Flow
-15.6M
↑ 115.92%
Investing Cash Flow
-6.0M
↓ 8.85%
Financing Cash Flow
39.7M
↓ 27.55%
FY19Y/Y Change
Operating Cash Flow
-17.8M
↑ 14.03%
Investing Cash Flow
-61.9M
↑ 938.09%
Financing Cash Flow
91.0M
↑ 129.52%
FY20Y/Y Change
Operating Cash Flow
-18.5M
↑ 4.28%
Investing Cash Flow
-69.7M
↑ 12.55%
Financing Cash Flow
46.7M
↓ 48.66%
FY21Y/Y Change
Operating Cash Flow
-13.1M
↓ 29.5%
Investing Cash Flow
-7.4M
↓ 89.37%
Financing Cash Flow
6.0K
↓ 99.99%
FY22Y/Y Change
Operating Cash Flow
-21.8M
↑ 66.62%
Investing Cash Flow
-113.4M
↑ 1429.77%
Financing Cash Flow
136.0M
↑ 2266133.33%
Q4 FY22Q/Q Change
Operating Cash Flow
-3.3M
↓ 44.85%
Investing Cash Flow
-23.2M
↓ 77.65%
Financing Cash Flow
-35.0K
↓ 100.03%
Q1 FY23Q/Q Change
Operating Cash Flow
-6.5M
↑ 93.39%
Investing Cash Flow
32.3M
↓ 239.11%
Financing Cash Flow
-36.0K
↑ 2.86%
Q2 FY23Q/Q Change
Operating Cash Flow
-4.4M
↓ 32.32%
Investing Cash Flow
-18.2M
↓ 156.4%
Financing Cash Flow
-2.0M
↑ 5552.78%

Technicals Summary

Sell

Neutral

Buy

Orthopediatrics Corp is currently in a neutral trading position according to technical analysis indicators.

More on Technical Analysis

Peers

Company Name1 Month6 Month1 Year3 Years5 Years
Orthopediatrics Corp
Orthopediatrics Corp
18.41%
24.61%
-23.3%
-45.21%
-5.85%
Stryker Corporation
Stryker Corporation
-3.84%
5.16%
12.86%
24.25%
52.69%
Boston Scientific Corp.
Boston Scientific Corp.
-3.68%
21.48%
41.72%
68.89%
76.47%
Edwards Lifesciences Corp.
Edwards Lifesciences Corp.
-34.8%
-18.49%
-34.85%
-45.17%
-15.86%
Abbott Laboratories
Abbott Laboratories
1.03%
-5.4%
-7.12%
-11.35%
20.75%
Medtronic Plc
Medtronic Plc
-1.99%
-9.34%
-13.21%
-38.74%
-23.49%
Company NameP/E RatioP/B RatioPEG RatioEPSROEROADiv YieldBVPS
Orthopediatrics Corp
Orthopediatrics Corp
246.27
NA
NA
-1.18
-0.06
-0.04
NA
15.74
Stryker Corporation
Stryker Corporation
38.91
38.91
2.92
11.95
0.19
0.07
0.01
50.33
Boston Scientific Corp.
Boston Scientific Corp.
63.22
63.22
1.8
2.37
0.09
0.05
NA
13.16
Edwards Lifesciences Corp.
Edwards Lifesciences Corp.
36.4
36.4
5.19
2.76
0.22
0.12
NA
12.35
Abbott Laboratories
Abbott Laboratories
33.84
33.84
5.99
4.66
0.15
0.06
0.02
22.31
Medtronic Plc
Medtronic Plc
28.97
28.97
1.52
5.2
0.07
0.04
0.04
38.29
Company NameAnalyst ViewMarket Cap5 Years Return %PE RatioProfit Margin
Orthopediatrics Corp
Orthopediatrics Corp
Buy
$805.5M
-5.85%
246.27
-13.58%
Stryker Corporation
Stryker Corporation
Buy
$129.7B
52.69%
38.91
16.03%
Boston Scientific Corp.
Boston Scientific Corp.
Buy
$114.3B
76.47%
63.22
12.05%
Edwards Lifesciences Corp.
Edwards Lifesciences Corp.
Buy
$52.4B
-15.86%
36.4
23.74%
Abbott Laboratories
Abbott Laboratories
Buy
$186.6B
20.75%
33.84
13.65%
Medtronic Plc
Medtronic Plc
Buy
$102.5B
-23.49%
28.97
11.36%

Insights on Orthopediatrics Corp

  • Increasing Revenue

    Revenue is up for the last 2 quarters, 37.61M → 44.68M (in $), with an average increase of 15.8% per quarter

  • Decreasing Net Profit

    Netprofit is down for the last 4 quarters, -2.88M → -7.80M (in $), with an average decrease of 40.5% per quarter

  • Vs BSX

    In the last 1 year, Boston Scientific Corp. has given 41.7% return, outperforming this stock by 65.0%

  • Vs BSX

    In the last 3 years, Boston Scientific Corp. has given 68.9% return, outperforming this stock by 114.1%

Institutional Holdings

  • Brown Capital Management, LLC

    11.72%

  • Brown Advisory Holdings Inc

    6.92%

  • BlackRock Inc

    5.11%

  • BRAIDWELL LP

    4.65%

  • Vanguard Group Inc

    3.71%

  • Wellington Management Company LLP

    3.07%

Company Information

orthopediatrics is the worldwide leader in pediatric orthopedics. we are the first company whose total focus is helping children with orthopaedic conditions and injuries by providing the surgeons who care for them with anatomically appropriate implants. every day, we focus purely on advancing the field of pediatric orthopedics through the innovative development of state-of-the-art technologies, commitment to quality products, and industry-leading support and clinical education with our experienced team of experts. our offering is continuing to expand as we strive to develop all of the necessary implants and instruments that a pediatric orthopedic surgeon needs to treat his/her patients, including: long bone deformity correction & trauma, spine, and sports medicine. as we continue to grow, we are looking for talented professionals to join our cause! visit our website to learn more about current openings, or submit a resume to careers@orthopediatrics.com!

Organization
Orthopediatrics Corp
Employees
247
CEO
Mr. Gregory A. Odle
Industry
Health Technology

Discover More

FAQs